Total sales of member companies of the five biotechnology-related organizations in the GTB area were calculated.
As stated in the Master Activity Plan, GTB has set the growth indicators (KPIs) to visualize the results of its activities. The prime KPI is the total sales of member companies of the five biotechnology-related organizations in the GTB area (listed companies and non-listed companies for which sales figures are available; hereinafter referred to as “member companies”), with the goal of expanding total sales from 102 trillion yen in FY2020 to 145 trillion yen by 2030 through annual growth of 3.6% (*The current status and target figures have been slightly revised due to the recalculation.). Here, we are pleased to announce that we have calculated the figures as of FY2021. […]
